Griffith K E, Joshi G P, Whitman P F, Garg S A
Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas 75235-9068, USA.
J Clin Anesth. 1997 May;9(3):204-7. doi: 10.1016/s0952-8180(97)00034-2.
To investigate the effects of priming rocuronium on the time course of neuromuscular blockade.
Prospective, controlled, randomized clinical study.
University teaching hospital.
42 ASA physical status I and II patients undergoing peripheral surgery with general anesthesia.
Following a standardized propofol-fentanyl induction, patients in Group 1 (n = 21) received a priming dose of rocuronium 0.06 mg/kg followed two minutes later by an intubating dose of rocuronium 0.54 mg/kg. Patients in Group 2 (n = 21) received a saline placebo injection followed two minutes later by rocuronium 0.6 mg/kg. Anesthesia was maintained with isoflurane and nitrous oxide 60% in oxygen.
Neuromuscular function was assessed at the wrist using mechanomyography with a single-twitch mode of stimulation at a frequency of 1 Hz until tracheal intubation and at 0.1 Hz thereafter. The times from injection of the intubating dose of rocuronium until 95% suppression of the twitch tension (onset time), recovery of twitch tension to 25% of control (clinical duration of action), and the time from 25% to 75% spontaneous recovery of twitch tension (recovery index) were recorded. The trachea was intubated at 95% depression of the twitch tension and the intubating conditions were graded using a 3-point scale. The onset times with priming rocuronium (34 +/- 6 s) were significantly shorter (p < 0.01) than those without priming (59 +/- 14 s). The intubation conditions were similar in the two groups; however, the intubating times with priming were significantly shorter. The clinical duration of action and the recovery index did not differ significantly between the two groups.
Priming rocuronium decreased the onset times and thus, the intubating times without increasing the clinical duration of action or recovery index.
探讨预注罗库溴铵对神经肌肉阻滞时间进程的影响。
前瞻性、对照、随机临床研究。
大学教学医院。
42例美国麻醉医师协会(ASA)身体状况为I级和II级、接受全身麻醉的外周手术患者。
在标准化的丙泊酚-芬太尼诱导后,第1组(n = 21)患者接受0.06 mg/kg的罗库溴铵预注剂量,两分钟后再给予0.54 mg/kg的罗库溴铵插管剂量。第2组(n = 21)患者先注射生理盐水安慰剂,两分钟后给予0.6 mg/kg的罗库溴铵。使用异氟烷和60%氧化亚氮(氧气中)维持麻醉。
在手腕处使用肌动电流描记法以1 Hz的单刺激模式评估神经肌肉功能,直至气管插管,之后以0.1 Hz评估。记录从注射罗库溴铵插管剂量至颤搐张力抑制95%(起效时间)、颤搐张力恢复至对照值的25%(临床作用持续时间)以及颤搐张力从25%自发恢复至75%的时间(恢复指数)。在颤搐张力抑制95%时进行气管插管,并使用3分制对插管条件进行分级。预注罗库溴铵的起效时间(34±6秒)显著短于未预注的起效时间(59±14秒)(p<0.01)。两组的插管条件相似;然而,预注组的插管时间显著更短。两组之间的临床作用持续时间和恢复指数无显著差异。
预注罗库溴铵可缩短起效时间及插管时间,且不增加临床作用持续时间或恢复指数。